Thomas Huenig
Directeur/Bestuurslid bij TeGenero AG
Oorsprong van het eerstegraads netwerk van Thomas Huenig
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
TeGenero AG
TeGenero AG Pharmaceuticals: MajorHealth Technology TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany.
4
| Private Company | Pharmaceuticals: Major | 4 |
Wuerzburg Schweinfurt University of Applied Sciences
1
| College/University | Other Consumer Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Thomas Huenig via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Director/Board Member | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Investment Managers | Founder | |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
University of Freiburg | College/University | Corporate Officer/Principal | |
SILTRONIC AG | Industrial Machinery | Director/Board Member | |
Amgen Research (Munich) GmbH
Amgen Research (Munich) GmbH Metal FabricationProducer Manufacturing Part of Amgen, Inc., Amgen Research (Munich) GmbH is a biotechnology company based in Munich, Germany. The company has over 850 employees working at two locations in Germany. Amgen Scholars Europe Programs offer practical research experience to 100 students from all over Europe every summer. The company utilizes biotechnological possibilities to develop innovative treatments for diseases. The company continuously develops new substances to provide biopharmaceuticals to patients worldwide with serious illnesses. The CEOs of the company are Peter Kufer and Robert Saller. Amgen Research (Munich was acquired by ECKA Granulate GmbH & Co. KG from Aurubis AG on June 13, 2002. | Metal Fabrication | Chief Tech/Sci/R&D Officer | |
Carl Zeiss AG
Carl Zeiss AG Electronic ComponentsElectronic Technology Carl Zeiss AG engages in the development and manufacture of scientific optics technologies and solutions services. Its products and solutions inlcude medical, microscopy, optemetry, industrial metrology spectroscopy, semicondictor technology, camera and film lenses, and simulation solutions planetariums. The company was founded by Carl Zeiss in 1846 and is headquartered in Oberkochen, Germany. | Electronic Components | Chief Executive Officer | |
Technische Universität München | College/University | Doctorate Degree | |
Carl Zeiss SMT GmbH
Carl Zeiss SMT GmbH SemiconductorsElectronic Technology Carl Zeiss SMT GmbH develops and manufactures lithography optics solutions and nanotechnology systems. It offers semiconductor equipment and lithography optics for wafer steppers and scanners. The company was founded in 2006 and is headquartered in Oberkochen, Germany. | Semiconductors | Chief Executive Officer | |
Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Undergraduate Degree | |
University of Regensburg | College/University | Undergraduate Degree | |
Max-Planck-Institute for Molecular Genetics | College/University | Doctorate Degree | |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
Carl Zeiss Industrielle Messtechnik GmbH
Carl Zeiss Industrielle Messtechnik GmbH Electronic Equipment/InstrumentsElectronic Technology Carl Zeiss Industrielle Messtechnik GmbH manufactures & supplies measuring equipment. The product range extends from the technology leader in portal and horizontal arm measuring instruments, and instruments for measuring the shape, contour and surfaces. Among the instruments, Carl Zeiss is setting new standards for use in production environments. With the expansion of service packages to full-service supplier of Industrial Metrology Division of the change comes from the equipment manufacturers to system providers. The division operates in the market so that the growing demands for services, thus securing the necessary growth. The company is headquartered in Oberkochen, Germany. | Electronic Equipment/Instruments | Chief Executive Officer | |
European Molecular Biology Organization | Corporate Officer/Principal | ||
VAT GROUP AG | Industrial Machinery | Director/Board Member | |
StartAngels Network
StartAngels Network Packaged SoftwareTechnology Services StartAngels Network operates as a platform for business angel investors. Its angle investors invest directly in the start-up companies, coach them, and provide useful contacts. The company was founded by Peter H. Müller in 2000 and is headquartered in Zurich, Switzerland. | Packaged Software | Director/Board Member | |
Reha-Stim Medtec AG
Reha-Stim Medtec AG Medical SpecialtiesHealth Technology YouRehab AG creates interactive therapy systems for neurological motor disorders. It offers YouGrabber, an all-in-one upper limb rehabilitation product for arms and fingers, which trains patients at peak intensity using rehabilitation gaming to enahcne clinical outcomes; YouKicker, a lower limb rehabilitation product for legs and feet. The company was founded by Oliver Ullmann, Kynan Eng, Edith Chevrier, Lisa Holper, Daniel Kiper, Pawal Pyk and Ewa Siekierka in April 2010 and is headquartered in Schlieren, Switzerland. | Medical Specialties | Director/Board Member | |
Advanced Osteotomy Tools - AOT AG
Advanced Osteotomy Tools - AOT AG Medical SpecialtiesHealth Technology Advanced Osteotomy Tools-AOT AG develops, manufactures, and markets medical devices and tools for bone-cutting. Its device combines three-dimensional (3D) pre-operative planning and a navigation system with a miniaturized laser mounted on a robotic arm. The company was founded by Alfredo E. Bruno, Philippe Cattin, Philipp Jürgens, and Hans-Florian Zeilhofer in 2011 and is headquartered in Allschwil, Switzerland. | Medical Specialties | Chairman | |
Platzerinvest AG | Director/Board Member | ||
Platzer Consult GmbH | Chief Executive Officer | ||
Leman Micro Devices SA
Leman Micro Devices SA SemiconductorsElectronic Technology Leman Micro Devices SA engages in the development of sensor and software systems that measures blood pressure, body temperature, blood oxygen saturation, heart rate and respiration rate in smartphone. The company was founded by Chris Elliott and Mark-Eric Jones in 2010 and is headquartered in Lausanne, Switzerland. | Semiconductors | Chairman | |
Bio-Bac, Inc.
Bio-Bac, Inc. Chemicals: SpecialtyProcess Industries Bio-Bac, Inc. specializes in biological treatment of organic waste through a bacterial bioaugmentation process. Its solutions include wastewater treatment, nitrification – ammonia degradation, ponds and water gardens, golf, hydrocarbons, household and commercial and agricultural treatment. The company is headquartered in Sherbrooke, Canada. | Chemicals: Specialty | Director/Board Member | |
HARPOON THERAPEUTICS, INC. | Biotechnology | Founder | |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Biotechnology | Founder | |
BC Platforms AG
BC Platforms AG Data Processing ServicesTechnology Services BC Platforms AG provides powerful genomic data management and analysis solutions. It offers pharmaceutical, biobank, healthcare and academia products. The company was founded by Timo Kanninen in 1997 and is headquartered in Basel, Switzerland. | Data Processing Services | Director/Board Member | |
TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Founder | |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Biotechnology | Founder | |
Helmholtz-Fonds eV | Investment Trusts/Mutual Funds | Director/Board Member | |
Physikalisch-Technische Bundesanstalt | Director/Board Member | ||
WEREWOLF THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
Dark Blue Therapeutics Ltd.
Dark Blue Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Dark Blue Therapeutics Ltd. operates as a biotechnology firm. The company was founded in June 4, 2020 an is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Autobahn Labs, Inc.
Autobahn Labs, Inc. Medical/Nursing ServicesHealth Services Autobahn Labs, Inc. is a virtual incubator that partners with research institutions to accelerate the advancement of early-stage drug discovery and development. The company is based in Palo Alto, CA. The organization invests intellectual, financial, and physical capital to efficiently move projects from feasibility to novel drug candidates. Autobahn Labs was created by Samsara Biocapital, Evotec, and KCK Ltd. | Medical/Nursing Services | Director/Board Member | |
CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
Panavance Therapeutics, Inc. | Director/Board Member | ||
Crossbow Therapeutics, Inc.
Crossbow Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Crossbow Therapeutics, Inc. is a biotechnology company that aims to improve the lives of people with cancer by developing next-generation immunotherapies. The company is based in Cambridge, MA, and the CEO of the company is Briggs W. Morrison. The company's T-bolt™ therapies are designed to target previously unreachable cancer cell targets with high precision. Crossbow's approach is efficient and selective, allowing them to target the entire universe of cancer proteins, which expands the potential of antibody therapy to address many types of cancer. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
AOT AG
AOT AG Medical SpecialtiesHealth Technology AOT AG develops and manufactures robotic surgery equipment. Its technologies include laser photoablation, navigation, planning, and image tools, and real time controlling systems. The company was founded in 2011 and is headquartered in Basel, Switzerland. | Medical Specialties | Director/Board Member |
Statistieken
Internationaal
Duitsland | 20 |
Verenigde Staten | 17 |
Zwitserland | 12 |
Canada | 3 |
Italië | 2 |
Sectoraal
Health Technology | 21 |
Consumer Services | 7 |
Commercial Services | 5 |
Electronic Technology | 5 |
Finance | 4 |
Operationeel
Director/Board Member | 26 |
Corporate Officer/Principal | 11 |
Founder | 9 |
Chairman | 9 |
Chief Tech/Sci/R&D Officer | 7 |
Sterkste connecties
Insiders | |
---|---|
Erich Maximilian Platzer | 31 |
Patrick Baeuerle | 19 |
Hermann Gerlinger | 9 |
Thomas Hanke | 4 |
Benedikte Hatz | 2 |
- Beurs
- Insiders
- Thomas Huenig
- Bedrijfsconnecties